PF-Atlas › Clinical Trials › NCT02558127

Asthma With Hypersecretion-associated Gene for Cystic Fibrosis

Asthma patients · Not specified

Registry ID
NCT02558127
Phase
Not specified
Status
Completed
Drug / intervention
Asthma patients
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Start
2015-05
Enrollment
100
Locations
1

About this trial

The combination of asthma and being a carrier of genetic variants (mutations and / or polymorphisms) in the CFTR gene variant would cause bronchial asthma with mucus hypersecretion. This phenotype is characterized by a more severe disease, in terms of control, quality of life, exacerbations and lung function, and a different asthma the bronchial hypersecretion without inflammatory phenotype.

View NCT02558127 on ClinicalTrials.gov →

Explore related

All Asthma patients trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02558127 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.